PRIMARY STUDY
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism
Key Findings: Two experiments show promise for behavioral improvement using ultramicronized PEA with luteolin in a mouse model of autism and a 10-year old patient with ASD.
Type of Study: Meta-analysis
Study Sample Size: 1
Study Result: Positive
Study Location(s): Italy, United States
Year of Pub: 2016
Cannabinoids Studied: Palmitoylethanolamide (PEA)
Phytocannabinoid Source: Not Applicable
Ligands Studied: Anti-inflammatory cytokines
